▼ SELL
$ Value
$5.9M
Shares
200,000
Price
$30
Filed
Apr 22
Insider
Name
Venker Eric
Title
President & Immunovant CEO
CIK
0001801917
Roles
Officer
Transaction Details
Transaction Date
2026-04-20
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,647,546
Footnotes
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.33 to $29.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. | Reflects an award of stock options to purchase Common Shares that is fully vested.
Filing Info
Venker Eric's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | ROIV | M | $770K |
| 2026-04-20 | ROIV | ▼ | $5.9M |
| 2026-04-20 | ROIV | M | $0 |
| 2026-04-07 | IMVT | A | $0 |
| 2026-04-07 | IMVT | A | $0 |
| 2026-04-02 | IMVT | ▼ | $308K |
| 2026-04-02 | IMVT | ▼ | $35K |
| 2026-04-01 | IMVT | M | $5.3M |
| 2026-04-01 | IMVT | D | $8.4M |
| 2026-04-01 | IMVT | M | $0 |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | — | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |